DIN 02535416 — TEVA-BUDESONIDE 0.25 MG
TEVA-BUDESONIDE is a suspension of Budesonide (Inhaled) marketed by TEVA CANADA LIMITED. The full Budesonide (Inhaled) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02535416
- Brand name
- TEVA-BUDESONIDE
- Active ingredient
- Budesonide (Inhaled)
- Strength
- 0.25 MG
- Dosage form
- SUSPENSION
- Route
- INHALATION
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Inhaled corticosteroid (ICS)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Budesonide (Inhaled) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02229099 | PULMICORT NEBUAMP 0.125 MG/ML | 0.125 MG | SUSPENSION | ASTRAZENECA CANADA INC | MARKETED |
| 01978918 | PULMICORT NEBUAMP 0.25 MG/ML | 0.25 MG | SUSPENSION | ASTRAZENECA CANADA INC | MARKETED |
| 01978926 | PULMICORT NEBUAMP 0.5 MG/ML | 0.5 MG | SUSPENSION | ASTRAZENECA CANADA INC | MARKETED |
| 00852074 | PULMICORT TURBUHALER | 100 MCG | POWDER (METERED-DOSE) | ASTRAZENECA CANADA INC | MARKETED |
| 00851752 | PULMICORT TURBUHALER | 200 MCG | POWDER (METERED-DOSE) | ASTRAZENECA CANADA INC | MARKETED |
| 00851760 | PULMICORT TURBUHALER | 400 MCG | POWDER (METERED-DOSE) | ASTRAZENECA CANADA INC | MARKETED |
| 02494264 | TARO-BUDESONIDE | 0.125 MG | SUSPENSION | TARO PHARMACEUTICALS INC | MARKETED |
| 02494272 | TARO-BUDESONIDE | 0.25 MG | SUSPENSION | TARO PHARMACEUTICALS INC | MARKETED |
| 02494280 | TARO-BUDESONIDE | 0.5 MG | SUSPENSION | TARO PHARMACEUTICALS INC | MARKETED |
| 02465949 | TEVA-BUDESONIDE | 0.125 MG | SUSPENSION | TEVA CANADA LIMITED | MARKETED |
| 02465957 | TEVA-BUDESONIDE | 0.5 MG | SUSPENSION | TEVA CANADA LIMITED | MARKETED |